» Articles » PMID: 37297957

MELD-Na Alterations on the Liver Transplant Waiting List and Their Impact on Listing Outcome

Overview
Journal J Clin Med
Specialty General Medicine
Date 2023 Jun 10
PMID 37297957
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Dynamic MELD deterioration (Delta MELD) during waiting time was shown to have significant impact on post-transplant survival. The aim of this study was to analyze the impact of MELD-Na score alterations on waiting list outcomes in liver transplant candidates.

Method: 36,806 patients listed at UNOS for liver transplantation in 2011-2015 were analyzed according to their delisting reasons. Several different MELD-Na alterations during waiting time were analyzed (e.g., maximal change, last change before delisting/transplantation). Outcome estimates were calculated according to MELD-Na scores at listing and Delta MELD.

Results: Patients who died while on the waiting list showed a significantly higher deterioration in MELD-Na during the waiting time (6.8 ± 8.4 points) than stable patients who remained actively listed (-0.1 ± 5.2 points; < 0.01). Patients who were considered too healthy for transplantation improved by more than 3 points on average during the waiting time. The mean peak MELD-Na alteration during the waiting time was 10.0 ± 7.6 for patients who died on the waiting list, compared to 6.6 ± 6.1 in the group of patients who finally underwent transplantation.

Conclusions: Deterioration of MELD-Na during waiting time and maximal MELD-Na deterioration have a significant negative impact on the liver transplant waiting list outcome.

References
1.
Finkenstedt A, Nachbaur K, Zoller H, Joannidis M, Pratschke J, Graziadei I . Acute-on-chronic liver failure: excellent outcomes after liver transplantation but high mortality on the wait list. Liver Transpl. 2013; 19(8):879-86. DOI: 10.1002/lt.23678. View

2.
Kamath P, Wiesner R, Malinchoc M, Kremers W, Therneau T, Kosberg C . A model to predict survival in patients with end-stage liver disease. Hepatology. 2001; 33(2):464-70. DOI: 10.1053/jhep.2001.22172. View

3.
Tang J, Ohri N, Kabarriti R, Aparo S, Chuy J, Goel S . Model for End-Stage Liver Disease and Sodium Velocity Predicts Overall Survival in Nonmetastatic Hepatocellular Carcinoma Patients. Can J Gastroenterol Hepatol. 2018; 2018:5681979. PMC: 6247644. DOI: 10.1155/2018/5681979. View

4.
Wiesner R, McDiarmid S, Kamath P, Edwards E, Malinchoc M, Kremers W . MELD and PELD: application of survival models to liver allocation. Liver Transpl. 2001; 7(7):567-80. DOI: 10.1053/jlts.2001.25879. View

5.
Xun Y, Shi J, Li C, Li D, Shi W, Pan Q . Prognostic performance of a series of model for end-stage liver disease and respective Δ scores in patients with hepatitis B acute-on-chronic liver failure. Mol Med Rep. 2014; 9(5):1559-68. PMC: 4020485. DOI: 10.3892/mmr.2014.1983. View